The Mayo Clinic
wwwIn 1996, Mayo Clinic and Novo Nordisk entered a strategic alliance within the field of evidence-based medicine with a focus on diabetes. The Mayo Clinic of the United States is one of the most reputable and innovative clinics in the world.
The partnership could eventually improve the management of diabetes and give easier access to best practice management guidelines.
The cornerstone of the partnership is clinical projects with focus on the jointly developed Diabetes Electronic Management System (DEMS) and clinical outcomes studies. In addition, the parties have established a research center that organises and executes research fellowships and other activities within basic medical research and clinical development. Another key alliance activity is the establishment of a continued medical education programme; that is, further education and training of health care professionals around the world in the diagnosis and treatment of diabetes.
To make a real difference to the patients we have to look beyond products and optimise efforts in all areas of the healthcare system. In the US, Novo Nordisk will continue to develop our partnership with the Mayo Clinic aiming at jointly developing tools to better organise and monitor the health care delivered. Partnerships with the Mayo Clinic, the Steno Diabetes Center and other prominent institutions allow for comparisons of health outcomes and treatment strategies/intensities. Such insights will benefit patients through better care and society through better use of the healthcare system's limited resources.
